Morepen Laboratories Ltd Quarterly Results

Q1 FY26-27 Results Summary

Revenue

The revenue stands at ₹570.13 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹570.13 crore. This corresponds to a year-on-year *(YoY) growth of 17.62 per cent.

Operating Profit

Operating Profit stands at ₹82.54 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹82.54 crore. This corresponds to a year-on-year *(YoY) growth of 237.59 per cent.

PBDT

PBDT stands at ₹82.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹82.88 crore. This corresponds to a year-on-year *(YoY) growth of 185.40 per cent.

Profit Before Tax

Profit Before Tax stands at ₹74.53 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹74.53 crore. This corresponds to a year-on-year *(YoY) growth of 220.01 per cent.

Net Profit

Net Profit stands at ₹56.35 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 0.00 per cent from ₹56.35 crore. This represents a 258.92 per cent year-on-year *(YoY) growth for the same year.

YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Morepen Laboratories Ltd News

Morepen Labs hits new high on huge volume; stock up 191% in 4 months

3 min read

Realty, pharma: Investors tap into domestic-economy focused sectors in H1

4 min read

Morepen Laboratories files its first US ANDA for sitagliptin tablets

2 min read

Morepen Labs rises 7% to 52-week high; what moved this multibagger stock?

2 min read

Morepen Labs zooms 112% in 6 weeks; stock hits multi-year high; here's why

4 min read

Morepen Labs spurts 20% to hit new 52-week high as Q1 profit zooms 394%

2 min read

Morepen Laboratories Ltd Earnings

YOY

QOQ

Category	Q1 FY26-27	Q1 FY25-26	Change %	FY25-26	FY24-25	Change %
Total Revenue	570.13	425.24	34.07	1,805.69	1,811.58	-0.33
Expenses	487.59	401.07	21.57	1,680.06	1,637.51	2.60
Other Income	5.18	4.41	17.46	47.14	18.36	156.75
Operating Profit	82.54	24.17	241.50	172.77	192.43	-10.22
Depreciation	8.35	9.03	-7.53	36.43	28.98	25.71
Interest	4.84	4.04	19.80	16.41	8.34	96.76
Profit Before Tax	74.53	15.52	380.22	119.93	155.12	-22.69
Tax	18.18	4.11	342.34	15.80	32.37	-51.19
Net Profit	56.35	11.41	393.87	95.65	118.02	-18.95

Category	Q1 FY26-27	Q1 FY25-26	Change %	FY25-26	FY24-25	Change %
Total Revenue	541.04	391.28	38.27	1,681.20	1,554.54	8.15
Expenses	461.44	372.33	23.93	1,569.12	1,401.12	11.99
Other Income	5.31	4.09	29.83	22.59	15.72	43.70
Operating Profit	465.92	329.13	41.56	134.67	169.13	-20.37
Depreciation	7.98	7.88	1.27	29.31	24.44	19.93
Interest	4.78	3.81	25.46	16.10	7.10	126.76
Profit Before Tax	72.15	11.35	535.68	89.26	137.59	-35.13
Tax	18.15	3.29	451.67	14.71	31.28	-52.97
Net Profit	54.00	8.06	569.98	66.06	101.58	-34.97

Category	Q1 FY26-27	Q4 FY25-26	Change %
Total Revenue	570.13	484.72	17.62
Expenses	487.59	460.27	5.94
Other Income	5.18	8.46	-38.77
Operating Profit	82.54	24.45	237.59
Depreciation	8.35	5.75	45.22
Interest	4.84	3.88	24.74
Profit Before Tax	74.53	23.29	220.01
Tax	18.18	7.59	139.53
Net Profit	56.35	15.70	258.92

Category	Q1 FY26-27	Q4 FY25-26	Change %
Total Revenue	541.04	462.81	16.90
Expenses	461.44	439.50	4.99
Other Income	5.31	8.82	-39.80
Operating Profit	465.92	388.75	19.85
Depreciation	7.98	0.63	1166.67
Interest	4.78	3.87	23.51
Profit Before Tax	72.15	27.62	161.22
Tax	18.15	7.50	142.00
Net Profit	54.00	20.12	168.39

Morepen Laboratories Ltd Research Reports

Action	Target Price (₹)	Broker	Date	Reports
Data Not Found

Morepen Laboratories Ltd Financial Reports

Data not available.

Morepen Laboratories Ltd Stock Prices Compare with Peers

Company	1 Day	1 Week	1 Month	3 Months	6 Month	1 Year
Morepen Labs.	-1.45%	-2.89%	9.95%	107.20%	206.35%	159.74%
Aarti Pharma	-0.01%	1.41%	6.78%	20.95%	24.10%	1.44%
Supriya Lifesci.	0.21%	3.05%	-0.69%	2.58%	39.12%	21.16%
Bliss GVS Pharma	-1.24%	1.16%	-4.10%	29.40%	151.45%	327.12%
Entero Healthcar	-1.27%	-5.19%	-8.53%	31.32%	26.61%	44.21%
Sanofi India	0.07%	1.49%	-3.87%	-12.41%	-16.03%	-36.30%
SPARC	-0.13%	3.45%	3.37%	-23.38%	26.03%	45.49%

Morepen Laboratories Ltd Corporate Information

Chairman / Executive Director / M D / Promoter: Sushil Suri

WTD & Executive Director: Sanjay Suri

Independent Non Exe. Director: Praveen Kumar Dutt

Independent Non Exe. Director: Ranjit Khattar

Independent Non Exe. Director: Savita

Independent Non Exe. Director: Sharad Jain

Company Secretary: Vipul Kumar Srivastava

Morepen Laboratories Ltd News

No More Data